CCL2 and breast cancer: Furthermore, BC significantly downregulated key pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α) (25.5% and 47.6%), IL-6 (9.1% and 49.0%), and C-C motif chemokine ligand 2 (CCL2) (16.3% and 28.1%).